CLINICAL TRIALS PROFILE FOR DARANIDE
✉ Email this page to a colleague
All Clinical Trials for DARANIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00494507 ↗ | Hyper- and Hypokalemic Periodic Paralysis Study | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 | 2007-06-01 | The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis. |
NCT00494507 ↗ | Hyper- and Hypokalemic Periodic Paralysis Study | Completed | University of Rochester | Phase 3 | 2007-06-01 | The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis. This study will also look at the long-term effects of Dichlorphenamide in periodic paralysis. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DARANIDE
Condition Name
Clinical Trial Locations for DARANIDE
Trials by Country
Clinical Trial Progress for DARANIDE
Clinical Trial Phase
Clinical Trial Sponsors for DARANIDE
Sponsor Name